Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure

Archive ouverte : Article de revue

Lewuillon, Clara | Guillemette, Aurélie | Titah, Sofia | Shaik, Faruk Azam | Jouy, Nathalie | Labiad, Ossama | Farfarellio, Valerio | Laguillaumie, Marie-Océane | Idziorek, Thierry | Barthélémy, Adeline | Peyrouze, Pauline | Berthon, Céline | Tarhan, Mehmet | Cheok, Meyling | Quesnel, Bruno | Lemonnier, Loïc | Touil, Yasmine

Edité par HAL CCSD ; MDPI

International audience. Acute myeloid leukemia (AML) is a hematological malignancy with a high risk of relapse. This issue is associated with the development of mechanisms leading to drug resistance that are not yet fully understood. In this context, we previously showed the clinical significance of the ATP binding cassette subfamily B-member 1 (ABCB1) in AML patients, namely its association with stemness markers and an overall worth prognosis. Calcium signaling dysregulations affect numerous cellular functions and are associated with the development of the hallmarks of cancer. However, in AML, calcium-dependent signaling pathways remain poorly investigated. With this study, we show the involvement of the ORAI1 calcium channel in store-operated calcium entry (SOCE), the main calcium entry pathway in non-excitable cells, in two representative human AML cell lines (KG1 and U937) and in primary cells isolated from patients. Moreover, our data suggest that in these models, SOCE varies according to the differentiation status, ABCB1 activity level and leukemic stem cell (LSC) proportion. Finally, we present evidence that ORAI1 expression and SOCE amplitude are modulated during the establishment of an apoptosis resistance phenotype elicited by the chemotherapeutic drug Ara-C. Our results therefore suggest ORAI1/SOCE as potential markers of AML progression and drug resistance apparition.

• Contient
• Sujet
• Description
• Oeuvre